A decades-long, widely-documented record of “miracle drug” marketing controversies and regulatory trouble may be what the market is really pricing.
Fosun’s Green Valley Deal: The Risk Isn’t…
A decades-long, widely-documented record of “miracle drug” marketing controversies and regulatory trouble may be what the market is really pricing.